Australia markets closed

Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
3.1300-0.0500 (-1.57%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 1.91B
Enterprise value 1.88B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.42
Price/book (mrq)3.28
Enterprise value/revenue 4.46
Enterprise value/EBITDA 25.14

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-28.05%
S&P500 52-week change 322.36%
52-week high 35.2800
52-week low 32.6300
50-day moving average 33.3972
200-day moving average 34.1723

Share statistics

Avg vol (3-month) 314.34M
Avg vol (10-day) 310.02M
Shares outstanding 5609.18M
Implied shares outstanding 6618.91M
Float 8471.55M
% held by insiders 127.22%
% held by institutions 10.68%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 410 June 2019
Last split factor 220:10
Last split date 320 Sept 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -2.99%
Operating margin (ttm)3.42%

Management effectiveness

Return on assets (ttm)-1.62%
Return on equity (ttm)-2.80%

Income statement

Revenue (ttm)409.77M
Revenue per share (ttm)0.67
Quarterly revenue growth (yoy)-8.80%
Gross profit (ttm)N/A
EBITDA -4.37M
Net income avi to common (ttm)-12.26M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)663.14M
Total cash per share (mrq)1.08
Total debt (mrq)636.53M
Total debt/equity (mrq)110.14%
Current ratio (mrq)8.84
Book value per share (mrq)0.94

Cash flow statement

Operating cash flow (ttm)24.83M
Levered free cash flow (ttm)-56.73M